Early progression on chemo-IO
69progressed at 4 months on chemo-IOECOG 2, CrCl 48
Docetaxel matched to her fitness, or another path?
46%
Fitness-matched docetaxel or a trial
54%
ADC, doublet or supportive care
What matters now
Phase 3 data now bring ADC combinations into the frontline choice between immunotherapy alone and combination treatment for metastatic NSCLC without actionable alterations.
69progressed at 4 months on chemo-IOECOG 2, CrCl 48
Docetaxel matched to her fitness, or another path?
46%
Fitness-matched docetaxel or a trial
54%
ADC, doublet or supportive care
71first-line NSCLC, intermediate TROP2COPD, CrCl 42
His COPD and the ADC: lung risk first, or overall fit?
26%
Drug-specific lung risk
74%
General fitness and markers
64first-line metastatic NSCLChigh PD-L1, high TROP2
Recommend a regimen, or lay out the options?
50%
A specific regimen
50%
A shared choice of options
66starting a TROP2 ADC combinationmild COPD, team new to the ADC
A fresh ADC baseline, or your current plan?
61%
A documented ADC baseline
39%
Existing plans or as-needed care
68cycle 2 of a TROP2 ADC combinationnew cough and infiltrate
New cough on the ADC: possible ILD, or something else?
63%
Possible ADC-related ILD
38%
A milder or familiar cause
What matters now
Phase 3 data now bring ADC combinations into the frontline choice between immunotherapy alone and combination treatment for metastatic NSCLC without actionable alterations.
5 Real World Scenarios
69progressed at 4 months on chemo-IOECOG 2, CrCl 48
Docetaxel matched to her fitness, or another path?
Where does the evidence land?
46%
Fitness-matched docetaxel or a trial
54%
ADC, doublet or supportive care
71first-line NSCLC, intermediate TROP2COPD, CrCl 42
His COPD and the ADC: lung risk first, or overall fit?
Where does the evidence land?
26%
Drug-specific lung risk
74%
General fitness and markers
64first-line metastatic NSCLChigh PD-L1, high TROP2
Recommend a regimen, or lay out the options?
Where does the evidence land?
50%
A specific regimen
50%
A shared choice of options
66starting a TROP2 ADC combinationmild COPD, team new to the ADC
A fresh ADC baseline, or your current plan?
Where does the evidence land?
61%
A documented ADC baseline
39%
Existing plans or as-needed care
68cycle 2 of a TROP2 ADC combinationnew cough and infiltrate
New cough on the ADC: possible ILD, or something else?
Where does the evidence land?
63%
Possible ADC-related ILD
38%
A milder or familiar cause